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Cryptococcus neoformans (C. neoformans var. grubii) is an environmentally acquired pathogen
causing 181,000 HIV-associated deaths each year. We sequenced 699 isolates, primarily C.
neoformans from HIV-infected patients, from 5 countries in Asia and Africa. The phylogeny of
C. neoformans reveals a recent exponential population expansion, consistent with the increase
in the number of susceptible hosts. In our study population, this expansion has been driven by
three sub-clades of the C. neoformans VNIa lineage; VNIa-4, VNIa-5 and VNIa-93. These
three sub-clades account for 91% of clinical isolates sequenced in our study. Combining the
genome data with clinical information, we find that the VNIa-93 sub-clade, the most common
sub-clade in Uganda and Malawi, was associated with better outcomes than VNIa-4 and
VNIa-5, which predominate in Southeast Asia. This study lays the foundation for further work
investigating the dominance of VNIa-4, VNIa-5 and VNIa-93 and the association between
lineage and clinical phenotype.
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C ryptococcus neoformans is an opportunistic fungalpathogen that primarily affects people with cell-mediatedimmune defects, particularly those living with HIV. There
are an estimated 223,100 incident cases of cryptococcal menin-
gitis per year in HIV patients with CD4 counts of <100 cells/µl,
resulting in 181,100 deaths1. Cryptococcus neoformans var. grubii
(hereafter C. neoformans), one of two varieties of C. neoformans,
accounts for the vast majority of cryptococcal meningitis cases
globally, particularly in the tropical and sub-tropical regions,
which bear the heaviest disease burden1,2.
The population structure of C. neoformans consists of at least
three lineages, VNI, VNII and VNB. Two of these, the frequently
isolated VNI and the rarely observed VNII, are clonal and
globally distributed3–5, while VNB is very diverse but rarely iso-
lated outside sub-Saharan Africa3 and South America6. Sequen-
cing of strains from patients with relapsed disease has indicated
that microevolution occurs during infection, with typically 0–6
single-nucleotide polymorphisms (SNPs) occurring over a med-
ian relapse period of 146 days7. Other studies have described a
broad view of the three main molecular types, VNI, VNII and
VNB, analysing 150–400 total isolates, and placing clinical iso-
lates into the context of environmental strains8–10. Within VNI,
three distinct, but still recombining, sub-lineages have been
identified, two of which (VNIa and VNIb) are globally dis-
tributed, while VNIc is limited to southern Africa. Genomic data
has revealed that VNI and VNII have more recent migrations
than VNB, with nearly clonal isolates found in disparate geo-
graphic regions9, although this has not yet been investigated on a
fine scale.
So far, our understanding of the population structure of C.
neoformans in the Asia and Pacific region, the second highest
prevalence region after sub-Saharan Africa1, has been based
upon low resolution methods such as multi-locus sequence
typing (MLST) and amplified fragment length polymorphism
(AFLP)4,11–16. These data show that C. neoformans in Southeast
Asia is highly clonal, with considerable gene flow between
countries within the region, and less connectivity with other
continents4. Recently, the first study focussing on whole-
genome data from the region has been reported, which iden-
tified 165 kbp of sequence specific to ST515, a sequence type
seen more frequently in HIV uninfected patients, the majority
of whom have no identified underlying immune-
suppression11,15. The predilection of ST5 to infect HIV-
uninfected patients is not the only reported association
between a C. neoformans lineage and a clinical phenotype.
Infections with VNB17 and VNI ST9318 have been reported to
have worse outcomes in HIV-infected patients in South-
ern Africa and Eastern Africa, respectively.
Previously, we have undertaken several prospective, descriptive
and randomized controlled intervention trials in Southeast Asia
and East/Southeast Africa19–21. Here, we use whole-genome
sequence analysis of 699 Cryptococcus isolates to describe the
population structure of C. neoformans causing disease in these
populations in high resolution, and combine this information
with metadata from these trials to relate this to disease phenotype.
We perform a detailed analysis of the obtained phylogenies,
phylogeographic analysis, recombination analysis, phylo-
temporal analysis, compare the mitochondrial and chromosome
phylogenies, and re-analyse outcomes from previous clinical trials
in the context of this new genomic information.
Results
Isolate characteristics. We sequenced 699 isolates, including all
available clinical isolates and 3 environmental C. neoformans
isolates. They were from Vietnam (n= 441), Laos (n= 73),
Thailand (n= 40), Uganda (n= 132) and Malawi (n= 13). There
were 696 clinical isolates from 695 patients, and 3 environmental
isolates (all from Vietnam). Of the total, 682 were C. neoformans,
12 were C. gattii and 5 (all from Uganda) were putative hybrids
between C. neoformans and C. deneoformans. All environmental
isolates were C. neoformans. There were 618 isolates from HIV-
infected patients and 78 from HIV-uninfected patients. Of the
682 C. neoformans, there were 681 isolates with mating type alpha
and 1 isolate from Vietnam with mating type a.
Whole-genome sequencing of VNI. Six hundred and seventy
eight (99.4%) of our C. neoformans isolates were VNI, while four
were VNII (Supplementary Fig. 1, Supplementary Data 1). To
provide context for our isolates, all 185 VNI genomes sequenced
by Desjardins et al.8 (160 clinical, 25 environmental, full details
available in Supplementary Data 1) were included in subsequent
phylogenetic analyses. We ensured technical comparability of our
methods of phylogenetic analysis with those of Desjardins et al.8
by comparing our results for the Desjardins data with their
reported results (Supplementary Fig. 2).
A phylogenetic tree (Fig. 1) was derived from the 325,812
variant positions in the core genome of the 863 C. neoformans
VNI. Of the novel C. neoformans isolates presented here, 668
were VNIa (97.9%), 10 were VNIb (1.5%); none were VNIc.
Figure 1 shows that the population structure of VNIa is
dominated by three common and highly clonal sub-clades, while
VNIb and VNIc are more heterogenous. VNIa, VNIb and VNIc
isolates were isolated from 14, 10 and 2 countries on 5, 6 and 1
continent(s), respectively (Supplementary Tables 1 and 2). VNIa
was predominant, accounting for 548 of 549 (99.8%) isolates in
Asia and 163 of 274 (59.5%) strains in Africa. When isolates from
Botswana, an established outlier in terms of Cryptococcus
neoformans diversity, were excluded, the proportion of VNIa
isolates in Africa was 84.3% (134 out of 159) of all VNI isolates.
The H99 reference genome belonged to VNIb.
Nine distinct clusters were identified using PCA and K-means
clustering (Supplementary Fig. 3). We extended the naming
scheme of Desjardins et al.8 to refer to the sub-clades within VNIa
as VNIa-4, VNIa-5, VNIa-93 and VNIa-32 after the predominant
MLST sequence type in each clade. Two clusters contained only
isolates with novel sequence types (STs), which we refer to as
VNIa-X and VNIa-Y. The previously described VNIb and VNIc
lineages were also identified as distinct clusters. We grouped the
remaining polyphyletic VNI isolates, which did not fall into any
PCA cluster into VNI-outlier. The numbers of each phylogenetic
group isolated from HIV positive patients from each country are
presented in Table 1.
While each country with more than 30 VNI isolates from HIV
infected individuals had a dominant or, in the case of Vietnam,
co-dominant sub-clade(s), there were minority sub-clades present
in every country analysed (Supplementary Fig. 4). For example,
VNIa-93, the dominant lineage in Uganda, was also present in
Vietnam (12%). Similarly, Uganda and Botswana had low
prevalence of typically Southeast Asian sub-clades, such as
VNIa-4 (Uganda= 1.6%, Botswana= 2.9%) and VNIa-5
(Uganda= 6.5%, Botswana= 4.9%).
Phylogenetic analysis of sub-clades within VNIa. We performed
fine-scale genomic epidemiological analyses of VNIa for every
sub-clade with at least 50 isolates from this study, that is, VNIa-4,
VNIa-5 and VNIa-93. These sub-clades accounted for 89% of the
isolates sequenced as part of our study, with VNIa-4 accounting
for 41%, VNIa-5 for 29% and VNIa-93 for 20%. To maximize the
phylogenetic resolution within these sub-clades, within sub-clade
reference genomes were generated using PacBio sequencing
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(PacBio genome assemblies available via FigShare https://doi.org/
10.6084/m9.figshare.6060686). The median SNP distance of the
VNIa-4, VNIa-5 and VNIa-93 strains to the within sub-clade
reference genome was 277 (standard deviation (SD)= 142), 338
(SD= 236) and 361 (SD= 44) SNPs, respectively, compared with
47,619 (SD= 196), 46,218 (SD= 245) and 48,763 (SD= 262) to
the H99 reference genome.
Recombination within sub-clades. Before deriving per sub-clade
phylogenies from which genomic-epidemiological characteristics
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Fig. 1 A whole-genome single-nucleotide polymorphism (SNP) phylogeny of all VNI in this study and Desjardins et al.8, constructed from 325,812 variable
positions. Nodes with <80% bootstrap support are highlighted by a blue circle. Scale bar is genetic distance in number of substitutions per site
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can be inferred, we quantified the extent to which recombination
plays a role in generation of diversity within sub-clades.
Recombination within sub-clades was investigated by assessing
the degree of linkage disequilibrium (LD). LD was assessed for all
within sub-clade SNPs with a minor allele frequency of 0.1 or
greater. There was limited decay of LD, indicating minimal
ongoing recombination (Supplementary Fig. 5).
Sub-clades include isolates from disparate locations. One of the
most striking patterns observed in the per-sub-clade phylogenies
is the interspersion of isolates from different countries and dif-
ferent continents throughout the phylogeny (see Fig. 2a–c),
indicating frequent international and intercontinental transmis-
sions. We used parsimony analysis to quantify the minimum
number of international transmission events that explain the
current geographic distribution of strains. VNIa-4 had the largest
number of international transmission events (primarily between
Thailand, Laos and Vietnam) as a proportion of total internal
branches (95% confidence interval (CI) in parentheses, VNIa-4=
13% (11–16%), VNIa-5= 8% (6–11%), VNIa-93= 10%
(7–14%)), while VNIa-93 had the highest proportion of inter-
continental branches (VNIa-4= 1% (0–2%), VNIa-5= 5%
(3–7%), VNIa-93= 7% (5–10%)).
Notable within sub-clade phylogenetic features. A striking
feature of the within sub-clade phylogenies is the combination of
long terminal branch lengths and short internal branches. The
median numbers of SNPs represented by the internal branch
lengths compared with the terminal branch lengths are 4.5 vs. 60
for VNIa-4 (P value from Kolmogorov–Smirnov test= 7 × 10–70),
3 vs. 77.5 for VNIa-5 (P value= 1 × 10–53) and 6 vs. 44.5 for
VNIa-93 (P value= 4 × 10–19) (Supplementary Fig. 6).
There were a total of 18,071, 17,593 and 7163 terminal branch
SNPs in VNIa-4, VNIa-5 and VNIa-93, respectively. We had only
Table 1 Frequency of isolation of VNI sub-clades from HIV-infected patients in each country from both this study and Desjardins
et al.8
Country VNIa-4 VNIa-5 VNIa-93 VNIc VNIb VNIa-32 VNIa-Y VNIa-X VNIa-outlier Total
Vietnam 175 129 44 1 15 1 1 366
Uganda 2 8 84 10 3 7 3 5 122
Botswana 3 5 3 74 2 3 6 3 3 102
Laos 57 6 2 65
Thailand 38 4 42
France 2 4 4 15 25
S. Africa 1 1 6 6 2 1 17
Malawi 3 5 2 1 2 13
Togo 2 2
India 1 1
Brazil 1 1
Argentina 1 1
Australia 1 1
USA 1 1
China 1 1
Japan 1 1
Tanzania 1 1
Total 278 163 143 80 38 24 14 11 11 762
a
b
c
0.0001
3 4
3 4
3 4
6
0.001
0.0001
Fig. 2 Within sub-clade phylogenetic trees for a VNIa-4, b VNIa-5 and c VNIa-93. Rings are numbered and coloured according to Fig. 1. Nodes with <80%
bootstrap support are denoted with blue circles. Trees were constructed from 24,956 (VNIa-4), 22,894 (VNIa-5) and 11,056 (VNIa-93) variable positions.
Scale bar is genetic distance in number of substitutions per site
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five environmental strains in our dataset (one VNIa-4 and four
VNIa-5, three from our study and two from Desjardins et al.8),
and they had a similar mean terminal branch length (75 SNPs).
There were 263, 294 and 31 variants (1.5%, 1.8% and 0.4% of
total), which occurred more than once on different terminal
branches in VNIa-4, VNIa-5 and VNIa-93. However, most of
these (VNIa-4, 52%; VNIa-5, 60%; and VNIa-93, 65%) were in
intergenic regions (i.e. not in coding sequence, 3′- or 5′-
untranslated region or introns). We manually investigated any
gene containing a variant that occurred as a homoplasy in three
or more strains for recognized links with virulence or host
interactions, but had no hits. The average dN/dS of SNPs in the
terminal branches were 0.84, 0.82 and 0.84 in VNIa-4, VNIa-5
and VNIa-93, respectively.
Another striking feature of the within sub-clade trees was the
number of polytomies. All internal branches that represented 0
SNPs were collapsed, resulting in 78, 65 and 35 collapsed
branches in 46, 36 and 21 distinct polytomies (defined as nodes
with more than 2 children, after branches of 0 SNPs were
collapsed) in VNIa-4, VNIa-5 and VNIa-93, respectively. The
collapsed branches as a proportion of the total number of
branches in each sub-clade were 13%, 15% and 12% in VNIa-4,
VNIa-5 and VNIa-93, respectively. The median number of
branches resulting from a polytomy event was 3 in all sub-clades,
while the maximum was 9, 11 and 6 in VNIa-4, VNIa-5 and
VNIa-93, respectively (Supplementary Table 3). For VNIa-4, 14
of 29 (48%) polytomies were international (i.e. strains in the
polytomy were isolated from more than one country) and 1 (3%)
of these was intercontinental. For VNIa-5, 10 of 24 (42%)
polytomies were international and 6 (25%) were intercontinental.
For VNIa-93, 4 of 21 (19%) polytomies were international and 1
(5%) of these was intercontinental. The maximum time
separating the sampling date of two isolates descending directly
from the same polytomy (i.e. not separated via an internal branch
representing >0 SNPs) was 10 years for VNIa-4, 15 years for
VNIa-5 and 8 years for VNIa-93. The median time range spanned
by polytomies was 5.5, 5 and 1 year(s) for VNIa-4, VNIa-5 and
VNIa-93, respectively. Genome sequences from isolates from
both our study and that of Desjardins et al.8 belonged to the same
polytomies.
We investigated the presence of nonsense mutations in DNA
mismatch repair genes. We found six isolates with nonsense
mutations in one of the 34 DNA mismatch repair genes we
investigated; all six isolates had different mutations, although
three strains had mutations in the same gene (CNAG_02073)
(Supplementary Table 6). The terminal branch lengths of isolates
with nonsense mutations in DNA mismatch repair genes were
not significantly longer than isolates without these mutations. The
mean terminal branch length of isolates with nonsense mutations
was 0.006 (SD= 0.012), while mean terminal branch length of
isolates without these mutations was 0.002 (SD= 0.009). There
was no significant difference between the distributions of branch
lengths (Wilcoxon’s rank-sum statistic, P value= 0.15).
Within sub-clade temporal patterns. The majority of isolates in
our study were collected during two clinical trials, which recruited
patients between 2004–2010 and 2013–2015 (Supplementary
Fig. 7A). As the first clinical trial only recruited patients in
Vietnam, this is the only country for which we have considerable
temporal range. These data show that two sub-clades, VNIa-4 and
VNIa-5, have been predominant in every year in which more
than five samples were taken since 2004 (Supplementary Fig. 7B).
The prevalence of VNIa-32 appears to have declined; in 2004 it
accounted for 12% (4/34) of C. neoformans collected, while there
were no cases of this sub-clade observed in 2014 (0/40), the last
year of collection.
We found a lack of clock like evolution within all three sub-
clades. The slope of the trend-line between time of isolation and
root to tip distance was negative for both VNIa-4 and VNIa-5.
There was a poor correlation between time of isolation and
distance from the root in the tree for all three sub-clades
(correlation co-efficient −0.07, −0.22 and 0.32 for VNIa-4, VNIa-
5 and VNIa-93) (Supplementary Fig. 8).
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Fig. 3 Kaplan–Meier survival estimates up to 6 months for all 530-HIV infected patients enroled in one of two clinical trials (Day et al.20; Beardsley et al.21)
with whole-genome sequencing results for their infecting isolate
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Association between sub-clade and clinical outcome. We used
data from our recent randomized controlled trials of treatment
for HIV-associated cryptococcal meningitis patients to define the
effect of sub-clade on survival until 10 weeks or 6 months after
randomization. We used a Cox proportional hazards regression
model with sub-clade as the main covariate, adjusted for country
and treatment. Complete data were available from 530 patients.
The survival over 6 months is illustrated in Fig. 3. Infections with
VNIa-93 were associated with a significantly reduced risk of death
by both 10 weeks and 6 months (hazard ratios (HR) 0.45, 95% CI
0.26–0.76, P= 0.003 and 0.60, 95% CI 0.39-0.94, P= 0.024,
respectively) compared with lineage VNIa-4 infections. There
were no differences in outcomes between infections with VNIa-4
and any other lineage (see Supplementary Tables 4 and 5).
Association between VNIa-5 and HIV-uninfected patients.
Vietnam was the only country with more than 10 isolates of C.
neoformans from HIV-uninfected people. Therefore, only isolates
from Vietnam were included in this analysis. Thirty five percent
of HIV-infected patients were infected with VNIa-5, compared
with 75% of HIV-uninfected patients (Fisher’s exact test, odds
ratio 5.4, 95% CI 2.8–10.8, P < 10–8). Isolates from HIV-
uninfected patients are interspersed throughout the entire
VNIa-5 phylogeny, implying that all strains of this cluster may
have the potential to cause infection in such hosts. HIV infection
status had no significant association with the terminal branch
length of VNIa-5 isolates.
VNIa-5 defining SNPs. Due to the association between VNIa-5
and disease in HIV-uninfected patients, we were interested in
SNPs which define VNIa-5. Ancestral sequence reconstruction
identified 7465 SNPs between the ‘origin’ of VNIa-5 and the most
recent common ancestor (MRCA) of VNIa-5, which were 95%
sensitive and specific for VNIa-5. There were 1868 non-
synonymous SNPs, distributed among 1220 genes. The dN/dS
ratio was calculated for all genes with SNPs on the VNIa-5
defining branch; there were no genes known to be associated with
virulence or interaction with the host that had extremes of dN/dS
ratio. The overall dN/dS ratio of genic SNPs on this branch was
0.33, compared with the SNPs on the VNIa-4 defining branch,
which had an overall dN/dS of 0.38. There were seven genes with
nonsense SNPs, introducing premature stop codons into five
hypothetical proteins, one E3 ubiquitin-protein ligase
(CNAG_04262) and a metacaspase, a cysteine protease involved
in cell apoptosis (CNAG_06787).
Mitochondrial sequence. A maximum likelihood phylogeny was
derived for the SNPs identified in the mitochondrial DNA
(mtSNP) of C. neoformans VNI (Supplementary Fig. 9B). When
the mtSNP tree was compared with the whole genome SNP
(wgSNP) tree (Supplementary Fig. 9B), some sub-clades were
phylogenetically congruous, while others were not. VNIa-4,
VNIa-5, VNIa-32 and VNIa-Y were all monophyletic within the
mtSNP tree, in agreement with the wgSNP tree (Supplementary
Fig. 9A). For VNIa-93, 144 out of 145 isolates were paraphyletic,
with the monophyletic VNIa-32 and VNIa-Y nested within the
VNIa-93 genotype, while VNIa-X was identical to the majority
mtSNP genotype of VNIa-93. In the mitochondrial phylogeny
VNIb is paraphyletic, giving rise to two sub-clades of VNIc, the
first contained 19 isolates, while the second is a singleton, and two
VNI-outlier isolates. The most parsimonious description for
VNIc is polyphyletic, with eight different mono- or paraphyletic
groups. The MRCA of all VNIc I in the mtDNA tree is the MRCA
of 648 isolates, only 89 of which are VNIc.
The most striking incongruity between the mtSNP and the
whole-genome data was in the placement of VNIa-5. In the
whole-genome tree, VNIa-5 is within the VNIa group with VNIa-
4 as its sister taxa. In contrast, in the mtSNP tree, VNIa-5 is an
outgroup, even in relation to VNIb and VNIc. There was a 28 bp
sequence, intergenic between CNAG_09008 and CNAG_09009
(positions 19,441 to 19,469 of the mtSNP sequence,
NC_018792.1), which contained eight variants, present in every
VNIa-5 in the dataset. This sequence begins 280 bp downstream
of the 3′ end of CNAG_09008 and terminates 200 bp upstream of
CNAG_09009. It had a per-site substitution rate of 0.28
compared with 0.004 for the VNIa-5 mitochondrial sequence as
a whole. None of the variant positions were shared by any other
C. neoformans strain, or by C. deneoformans JEC21
(GCA_000091045) or C. gattii R265 (GCA_000149475). When
the putative recombinant region was compared against the full
nr/nt BLAST database, the closest hit was to C. neoformans H99,
chromosome 5 (NC_026749.1), positions 80,207 to 80,234, which
had 1 bp difference (E value= 0.004). This closest sequence on
chromosome 5 is within CNAG_06848, which is widely
conserved in the fungal kingdom. CNAG_06848 is a 222 bp gene
encoding an ‘ATP synthase subunit 9, mitochondrial’. There were
no strains in our dataset with SNPs in CNAG_06848, which could
indicate a reciprocal recombination event. The assembly of the
PacBio-sequenced VNIa-5 genome also showed the presence of
the highly variable region in the mitochondrial genome
Discussion
We sequenced 699 isolates of C. neoformans covering 19 years
and 5 countries on 2 continents, with most isolates derived from
two large clinical trials. We integrated our novel data with pre-
viously published data8 to provide extra context for our original
findings. This context allowed us to assign 99.4% of the C. neo-
formans isolates sequenced as part of this study to the global clade
VNI3–5. According to the nomenclature established by Desjardins
et al.8 98.5% of our isolates belonged to VNIa, compared with
30% of clinical VNI isolates and 18.5% of all isolates sequenced by
Desjardins. To some extent, this difference is to be expected due
to the focus of Desjardins et al.8 on both VNI and VNB, and their
intensive sampling of Botswana, a known outlier in terms of
Cryptococcus diversity3. This dominance of VNIa in our samples
is interesting for two reasons. It raises the question of whether
there are specific biological properties of VNIa, or of VNIa-4,
VNIa-5 and VNIa-93, which underlie their predominance in our
clinical isolates. Secondly, the C. neoformans reference strain,
H99, belongs to the VNIb lineage, which accounts for fewer than
1.5% of the clinical isolates in our study. We suggest that it may
be useful to the Cryptococcus research community to consider
including more representative isolates (i.e. from VNIa) in detailed
laboratory investigations.
The structure of the phylogeny, with large ‘flat’ clades sepa-
rated by deep branches, and short internal branches combined
with long terminal branches within those clades, is consistent
with recent, exponential population expansion22,23. That C.
neoformans should have undergone a recent population expan-
sion is not surprising, considering the increase in the number of
susceptible hosts due to the HIV/AIDS epidemic. What is sur-
prising in our dataset is that this rapid expansion is due almost
entirely to three sub-clades, with 89% of C. neoformans sequenced
in this study belonging to the VNIa-4, VNIa-5 and VNIa-93 sub-
clades. Two other features consistent with an exponentially
increasing population size are (i) the lack of a molecular clock in
these sub-clades and (ii) the higher dN/dS of SNPs on terminal
branches compared with the lineage defining branches. The
dominance of these three sub-clades also explains the fact that
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even though 97.9% of our C. neoformans isolates were VNIa, we
observed little diversity within VNIa that was not also observed in
the 59 VNIa isolates sequenced by Desjardins et al.8.
Since the human host is thought to be a dead end for C.
neoformans, the dominance of these sub-clades cannot be due to
amplification through rounds of human infection and release into
the environment. Therefore, it either reflects the environmental
prevalence in the areas from which our study population become
infected, or there could be some properties of these sub-clades
which increase their ability to cause human infection. Further
ecological and biological studies are required to determine which
of these is the case. We also believe that any future environmental
sampling work should consider the possible role of a quiescent
phase of the C. neoformans life cycle, whether that is a spore,
desiccated yeast, or the recently described viable but non-
culturable form24. A resilient quiescent phase would increase the
ability of C. neoformans to travel long distances, a phenomenon
we have observed frequently in our data. Polytomies, which we
observed frequently in the C. neoformans phylogeny, have also
been observed in the phylogenies of bacterial spore formers25,26.
The phylo-geography of VNIa is characterized by each lineage
being predominantly but not exclusively found in a single country
or continent. While our sampling is exclusively from Asia and
Africa, and is therefore not globally representative, VNIa-4 and
VNIa-5 were predominantly Asian (97 and 89%), and VNIa-93
was predominantly African (64%). This finding is consistent with
previous reports, with particular STs having been reported to be
more common in certain countries, regions or continents3–5,16.
However, whole-genome sequence (WGS) provides us with extra
resolution in resolving whether, for example, the 7% of VNIa-5
strains in Africa are the result of a single introduction or multiple
discrete introductions. To address this question, we generated
within sub-clade reference genomes using PacBio sequencing and
performed within sub-clade phylogenetic analyses. Examination
of the within sub-clade phylogenetic trees (Fig. 2) and parsimony
analysis shows that international and intercontinental transmis-
sion is a frequent event, with 8–13% of internal branches repre-
senting an international transmission.
While nearly clonal isolates have been identified in disparate
locations by a recent study9, the authors focussed more on
exploring ancient migrations. Our data dramatically illustrate the
extent of this on-going intercontinental migration and we offer
two alternative explanations. The first potential explanation is
that transmission between countries or continents occurs during
latent infection, that is, a patient is exposed in one country, and
then travels to another country where they develop illness and are
sampled. Such long distance latent transmission has been hypo-
thesized previously27. Unfortunately, we do not have extensive
travel/residence histories for our patients and thus cannot directly
address this hypothesis. However, we judge it an unlikely expla-
nation of our findings given the limited extent of contemporary
migration between, for exampe, Vietnam and Uganda and the
demographics of our patient population (little disposable
income). A second, broad hypothesis to explain the large number
of transmission events is that they are mediated by environmental
factors, either ‘natural’ or human influenced. Potential natural
environmental factors would include air currents or migratory
birds; pigeons specifically are considered the most probable vector
for global dissemination28. Human activities that link the envir-
onments of East/Southeast Africa and Southeast Asia include
trade in lumber, rice, exotic animals and illegal animal products
such as those used in traditional medicine, for exampe, ivory
(http://www.aljazeera.com/news/2016/11/exclusive-vietnam-
double-standards-ivory-trade-161114152646053.html). While we
cannot directly address this hypothesis with our data, airborne
spread is well established as a long distance dispersal mechanism
for plant pathogens29. Intuitively it might seem unlikely that
long-distance airborne dispersal of fungal pathogens occurs fre-
quently. However, if airborne spore dispersal conforms to a non-
exponentially bound (or ‘fat-tailed’) distribution model rather
than an exponential model, long-distance dispersions will occur
relatively frequently29,30. Weather patterns are a proto-typical
example of such ‘fat-tailed’, ‘chaotic’ (small differences in initial
conditions, leading to large differences in outcome) distribu-
tions31. However, effective quantification of the potential con-
tribution of airborne dispersal is complex32 and beyond the scope
of this paper. Overall, we consider environmental factors to be the
better explanation because (i) Cryptococcus is fundamentally an
environmental organism, (ii) there is limited contemporary
human migration between Southeast Asia and East/Southeast
Africa and (iii) long-distance dispersal by environmental factors,
including wind, is well established for fungal pathogens.
Desjardins et al.8 established that there is still recombination
on-going within VNIa. However, within each sub-clade, recom-
bination appears to be a relatively minor contributor of genetic
diversity. LD decay over genomic distance was minimal in all
three sub-clades, although the small number of SNPs with a
minor allele frequency >0.1 (due to short internal branches)
means that this analysis had limited power. However, further
evidence against the role of recombination in the generation of
within sub-clade diversity is the low proportion of terminal
branch SNPs that are homoplasies.
We observed two associations between lineage and clinical
phenotype. First, the previously described association between
VNIa-5 and the infection of apparently immunocompetent HIV-
uninfected patients15,19, and second, the novel finding of a sig-
nificantly lower risk of death at 10 weeks in patients infected with
VNIa-93, in contrast to previous findings18. As VNIa-93 is pri-
marily found in Africa, and outcomes are typically worse in
Africa21, it is notable that we still observed this effect. We also
investigated whether there is evidence of within-host evolution
reflecting pressure from the host, as has been previously
observed7, by looking for convergent evolution on terminal
branches. This analysis found little evidence of significant within-
host evolution; there were no known virulence-associated genes
with extremes of dN/dS due to terminal branch mutations, and
only a small proportion (1.5%, 1.8%, 0.4%) of terminal branch
SNPs for each sub-clade were homoplasies, and the majority of
these were in intergenic regions.
One interesting difference between the VNIa-5 isolates and the
rest of VNIa was identified in the mitochondrial sequence. We
observed a 21 bp sequence, representing a probable recombination
event, which introduced eight SNPs present in every VNIa-5 isolate
and absent in every non-VNIa-5 isolate. The most likely candidate
for the donor sequence was chromosome 5 of the C. neoformans
nuclear genome, which encodes a sequence that varies by only 1 bp
from the 21 bp putative recombinant fragment. While this has not
been described previously in the literature, since the SNPs at these
positions were not mixed, and the reads containing the divergent
sequence mapped well to the mtDNA, and the PacBio sequence
showed the same sequence, we deem it likely that the mitochondrial
sequence has been accurately re-constructed, while the origin of the
divergent sequence is less certain. That this change occurs in the
mitochondrial genome is particularly intriguing as changes in
mitochondrial morphology have been reported as underlying the
hyper-virulence of the Vancouver outbreak C. gattii33,34. Whether
the changes in the C. neoformans mitochondrial genome lead to
morphological and in vitro phenotype changes as has been shown
for C. gattii is an important future research question. The putative
recombination is in an intergenic region of the mitochondrial
genome, so if this variant underlies a modified phenotype, it is
likely driven by changes in gene expression. Fungal mitochondrial
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5′ untranslated leader sequences have been described between 81 to
220 bp in length35, while the putative recombination occurs 200 bp
upstream of CNAG_09009.
In summary, our analysis of 699 Cryptococcus genomes has
revealed that clinical isolates of C. neoformans from Vietnam,
Laos, Thailand, Uganda and Malawi are concentrated in three
main sub-clades. The phylogenetic structure indicates that there
has been a recent exponential population expansion of C. neo-
formans, likely due to the increase in the number of people sus-
ceptible to infection. Our data show that, unexpectedly, three sub-
clades of C. neoformans (VNIa-4, VNIa-5 and VNIa-93) have
driven this population expansion; the reasons for this remain
uncertain and are a key question for future study. Another
research question raised by our findings is whether the mito-
chondrial recombination we observed in VNIa-5 is associated
with mitochondrial morphology changes, which could explain the
ability of this sub-type to infect HIV-uninfected people. We also
show that infection with VNIa-93, which has previously been
associated with poorer outcomes, is associated with a significantly
reduced risk of death by 10 weeks compared with VNIa-4.
Genome sequencing for fungal pathogens can provide insight into
clinical and epidemiological features, and pose important future
research questions for the field.
Methods
Strain selection. The Vietnamese isolates (N= 441) were clinical isolates from the
cerebrospinal fluid of patients enroled in a prospective, descriptive study of HIV-
uninfected patients with central nervous system infections (n= 67) between 1997
and 2014, a randomized controlled trial of antifungal therapy in HIV-infected
patients between 2004 and 2011 (http://www.isrctn.com/ISRCTN95123928), the
CryptoDex trial (http://www.isrctn.com/ISRCTN59144167) and three environ-
mental isolates from Ho Chi Minh City, Vietnam11,19–21. The WGS of eight
Vietnamese strains in this analysis have been previously reported15. Lao isolates
were from 73 patients with invasive cryptococcal infection admitted to Mahosot
Hospital, Vientiane, between 2003 and 2015, including 5 from the CryptoDex trial.
Isolates from Uganda (132), Malawi (13) and Thailand (40) were all from HIV-
infected patients enroled into the CryptoDex trial21. Sixty-nine isolates from
Vietnam and eight from Laos were derived from patients who were HIV unin-
fected. All clinical trials had ethical approval from the local IRB in each centre and
from the Oxford Tropical Ethics Committee, UK. All participants in clinical trials
gave written informed consent.
Micro and molecular biology. Isolates were revived from storage by incubation on
Sabouraud’s agar at 30 °C for 72 h. Single colonies were spread for confluent
growth and incubated at 30 °C for 24 h. For Illumina sequencing, genomic DNA
was extracted from approximately 0.5 g (wet weight) of yeast cells using the
MasterPure Yeast DNA purification kit (Epicentre, USA) according to the man-
ufacturer’s instructions. Colonies were grown overnight on YPD media (Merck,
UK), suspended in lysis solution, vortexed and incubated at 65 °C for 1 h. Forty
micrograms of RNase were added with incubation for 30 min at 37 °C, followed by
70 °C for 10 min. Following cooling on ice, 150 μL of MPC protein precipitation
reagent was added with further vortexing (10 s). Cellular debris was pelleted by
centrifugation for 10 min at 10,000 rpm. The supernatant was transferred to a clean
tube and 500 μL of isopropanol was added, mixed by inversion and re-centrifuged
for 10 min. The supernatant was discarded and the pellet was washed with 300 μL
of 75% ethanol. Following further centrifugation for 2 min, the ethanol supernatant
was discarded and the tube was placed on a 65 °C heat block to dry (30 s to 1 min)
DNA and then was re-suspended in 50 μL of dH2O. Whole-genome sequencing
was carried out on the Illumina HiSeq 2000 at the Sanger Institute UK, and
commercially through Macrogen, Korea using the HiSeq 4000 platform.
DNA for PacBio sequencing was extracted using a modification of the method
described at dx.doi.org/10.17504/protocols.io.ewtbfen. High-quality DNA was
extracted by bead beating freeze-dried cell pellets, followed by phenol/chloroform
purification and DNA precipitation with isopropanol. Briefly, purified single
colonies were grown overnight in 5 mL YPD. Cells were washed in phosphate-
buffered saline (PBS), suspended in 1 mL PBS and then lyophilized for 3 h using a
FIRSTEK BFD 4.5/50 freeze-dryer (FIRSTEK, Middlesex, UK). Lyophilized cells
were then homogenized using 3 mm Pyrex beads and a bead beater (3 × 60 s).
Homogenized cells were lysed in lysis buffer with 1% polyvinylpyrolidone at 64 °C
prior to the addition of RNAse T1 and proteinase K and resuspension in lysis
buffer. Following incubation at room temperature for 1 h with regular tube
inversion, 5 M potassium acetate was added with incubation on ice for 5 min. The
suspension was spun at 5000 × g at 4 °C for 10 min and repeated. The supernatant
was transferred for chloroform:isoamylalcohol (24:1) extraction and again spun at
4 °C, 4000 × g for 10 min. The resultant supernatant was aliquoted and treated with
RNase A/T1 and incubated at room temperature for 30 min. Then, the supernatant
was aliquoted and mixed with sodium acetate; DNA was precipitated with
isopropanol and harvested using pipette tips. PacBio sequencing was performed by
Macrogen, Seoul, Korea, for 20 kb SMRT library production, with two SMRT cells
per sample, according to the manufacturer’s instructions.
Species identification, principal components analysis. Species identification was
carried out using mash screen function36 comparing the sample FASTQs against
the whole refseq database. For the principal components analysis, all variant
positions were loaded into an adegenet37 (devel branch, commit 43b4360) genlight
object using RStudio. Then, the ade4 dudi.pca function was used to determine the
principal components. K-means clustering was run on the first two principal
components, with values to K between 2 and 10. The total within-cluster sum of
squares was plotted for each K, and the number of clusters determined as the
‘elbow’ in the plot of K vs. total within-cluster sum of squares. As the previously
described VNIb and VNIc were grouped into one cluster in the analysis of the first
two PCs, the same analysis was carried out on the third and fourth PCs, which
separated these two established lineages.
Phylogenetic analysis. FASTQ data were mapped against the H99 reference
(GCF_000149245) using bwa mem38, SNPs were called using GATK v3.3.039 in
unified genotyper mode. Positions where the majority of allele accounted for <90%
of reads mapped at that position, which had a genotype quality of <30, coverage
<5×, or mapping quality <30 were recorded as Ns in further analyses. These steps
were carried out using the PHEnix pipeline (https://github.com/phe-
bioinformatics/PHEnix) and SnapperDB40. Positions in which at least one strain
had an SNP passing quality thresholds were extracted and used as the input for IQ-
TREE v1.641 maximum likelihood phylogenetic analysis with the best-fitting model
selected by IQ-TREE. Ancestral state reconstruction was carried out using IQ-
TREE v1.642. To place our data into the broadest possible context, we included
WGS data from Desjardins et al. 8. To ensure efficient use of computational
resources, a preliminary phylogenetic analysis was carried out, including all our
data and representatives of VNI, VNBI, VNBII and VNII from Desjardins et al.8.
For polytomy analysis, ete343 was used to delete/collapse nodes (branches) in the
tree that represented 0 SNPs. Any node in this new tree with collapsed branches
with three or more children was defined as a polytomy. Pacbio data was assembled
using Canu v1.544 and default parameters, polishing with Illumina data from the
corresponding isolate using Pilon v1.2245 for multiple rounds until the number of
indels being corrected per round was <2. We searched for nonsense mutations in
the following 34 genes (CNAG_00178, CNAG_00550, CNAG_00572,
CNAG_00612, CNAG_00720, CNAG_00770, CNAG_00772, CNAG_01037,
CNAG_01642, CNAG_01916, CNAG_02073, CNAG_02490, CNAG_03449,
CNAG_05201, CNAG_05862, CNAG_06724, CNAG_07552, CNAG_07599,
CNAG_00299, CNAG_00328, CNAG_01163, CNAG_02512, CNAG_02771,
CNAG_03160, CNAG_04733, CNAG_05102, CNAG_05531, CNAG_06384,
CNAG_02467, CNAG_02544, CNAG_05198, CNAG_05537, CNAG_05746,
CNAG_06143), which includes the ERCC, MLH, MSH and RAD families of
proteins.
Analysis of effect of sub-clade on outcome. We assessed the effect of sub-clade
on time to death (10 weeks and 6 months) in HIV-infected patients with crypto-
coccal meningitis with a Cox proportional hazards regression model with sub-clade
as the main covariate. We included all patients with available data from our two
randomized controlled trials. The model was adjusted for country, induction
antifungal treatment (amphotericin monotherapy for 4 weeks, amphotericin
combined with flucytosine for 2 weeks, or amphotericin combined with fluconazole
for 2 weeks) and the use of adjunctive treatment with dexamethasone20,21. We
tested the proportional hazard assumption based on scaled Schoenfeld residuals.
Since we knew from the Cryptodex trial that the covariate dexamethasone does not
satisfy this assumption, we included a time varying coefficient for
dexamethasone use.
Recombination analysis. Recombination analysis was carried out independently
for VNIa-4, VNIa-5 and VNIa-93. LD (R2) was calculated on a per-lineage basis
using vcftools v0.1.1446 and the –geno-r2 option and a minimum allele frequency
(MAF) of 0.1, LD was grouped in 100,000 bp windows as there were not many
SNPs with an MAF >0.1 within sub-clades due to the short internal branches.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All sequence data from this study is publicly available at EBI ENA under BioProject
accessions PRJEB27222 and PRJEB5282. Per-sample accessions are available in
Supplementary Data 1, which is available as an Excel file from https://doi.org/10.6084/
m9.figshare.7796147.v1. All other data are available upon request.
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